EyeSense Attracts QIAGEN as Strategic Investor
January 11, 2011
BASEL, Switzerland - EyeSense AG, a leading developer of novel ophthalmic self-diagnostic systems for glucose monitoring of diabetes patients, today announced that it has entered into a strategic partnership with QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA). Capitalizing on QIAGEN's ESE fluorescence-based optical technology and on Eyesense's glucose sensing technology, the partners intend to develop [...]
Hach Announces HQd Benchtop Laboratory Meter and Ammonia Ion Selective Electrode Probe
January 11, 2011
Hach further expands its comprehensive line of HQd digital meters and plug-and-play IntelliCAL™ probes Loveland, Colo. - Hach Company (www.hach.com) announces the expansion of its electrochemistry offering with the new HQd Benchtop meter and IntelliCAL™ ammonia ion selective electrode (ISE) probe. Designed to accurately test water quality, the Hach HQd benchtop meter and ammonia probe [...]
Agilent Technologies Secures Patent for Porous Shell LC Particle Manufacturing Technology
January 11, 2011
SANTA CLARA, Calif. - Agilent Technologies Inc. (NYSE: A) today announced that it was awarded a U.S. patent for the process used to apply the superficially porous shell to particles in Agilent Poroshell 120 high-performance liquid chromatography (HPLC) columns. The patent was issued for the unique coacervation process used to manufacture the Poroshell 120 silica. [...]
New Genedata Screener Presented at CHI High Content Analysis Conference
January 11, 2011
Screener 9 delivers an enterprise hub for HCS data, linking multiple instruments and image management systems to create cost efficiencies and improved productivity San Francisco, Calif. - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced a new version of Genedata Screener®, a comprehensive software system for [...]
January 11, 2011
Germantown, MD., and Hilden, Germany - QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) has signed an agreement for the acquisition of a strategic stake in Alacris Theranostics GmbH, a German start-up company using novel technologies to develop individualized cancer treatment strategies based upon a patient's genomic profile, and for the acquisition of an exclusive option [...]
StemCells, Inc. Closes $10 Million Common Stock Financing
January 11, 2011
PALO ALTO, Calif. - StemCells, Inc. (Nasdaq:STEM) announced today that it has closed the sale of 10 million shares of common stock, at a fixed price of $1.00 per share. The Company received total proceeds, net of offering expenses and placement agency fees, of approximately $9.4 million. The common stock was sold in a registered [...]
January 11, 2011
Highly Efficient, Reproducible Non-Cytotoxic Transfection Reagent GenePORTER® Gold from AMSBIO is a new highly efficient and reproducible lipid-based reagent for effective transfection of a wide variety of cell lines. Molecular target delivery faces many barriers, from crossing the cell type-specific extracellular membrane, to cytoplasmic degradation and translocation across the nuclear membrane. To be effective, the [...]
Agilent Technologies Secures Patent for Porous Shell LC Particle Manufacturing Technology
January 11, 2011
Agilent Technologies Inc. (NYSE: A) today announced that it was awarded a U.S. patent for the process used to apply the superficially porous shell to particles in Agilent Poroshell 120 high-performance liquid chromatography (HPLC) columns. The patent was issued for the unique coacervation process used to manufacture the Poroshell 120 silica. The process applies the [...]
Caliper Announces Launch of LabChip(R) Dx for Molecular Diagnostics
January 11, 2011
LabChip Dx Provides Rapid, Accurate and Cost Effective Advanced Nucleic Acid Separations Capability to Clinical Research Laboratories HOPKINTON, Mass. - Caliper Life Sciences, Inc. (Nasdaq: CALP) today announced the launch of Caliper's new, innovative LabChip Dx system for use by clinical research laboratories developing molecular diagnostic tests. The LabChip Dx platform is now available in [...]
January 10, 2011
CAMBRIDGE, Mass. - BioScale Inc., an innovative life science company that develops, manufactures and promotes novel analytical tools enabling advancements in protein research, announced that results from the analysis of two pharmacodynamic biomarkers using the Acoustic Membrane MicroParticles (AMMP™) assay technology on the ViBE Protein Analysis Workstation were published in the peer-reviewed Elsevier Journal of [...]

